首页 | 本学科首页   官方微博 | 高级检索  
     

内皮祖细胞在缺血性脑血管病中的转化研究
引用本文:邹楠,王硕. 内皮祖细胞在缺血性脑血管病中的转化研究[J]. 中国卒中杂志, 2013, 8(5): 412-416
作者姓名:邹楠  王硕
作者单位:100050 北京首都医科大学附属北京天坛医院神经外科
摘    要:内皮祖细胞(endothelial progenitor cells,EPCs)是血管内皮细胞的前体细胞,它既参与胚胎时期的血管发育、形成,也对出生后的成体血管起到新生、修复、重建等极其重要的作用。随着转化医学(translational medicine)理念的提出与深入,越来越多的学者将EPCs及其生物学特性引入到缺血性脑血管病的基础与临床研究中。本文就近几年血管EPCs在缺血性脑血管病中的转化研究做一简要综述。

关 键 词:内皮祖细胞  脑血管病  缺血性  转化医学  
收稿时间:2012-09-28

Translational Research for Endothelial Progenitor Cells in Ischemic Cerebrovascular Disease
ZOU Nan,WANG Shuo.. Translational Research for Endothelial Progenitor Cells in Ischemic Cerebrovascular Disease[J]. Chinese Journal of Stroke, 2013, 8(5): 412-416
Authors:ZOU Nan  WANG Shuo.
Affiliation:Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
Abstract:Endothelial progenitor cells(EPCs) are the precursor cells of the vascular endothelial cells. EPC not only participate in both embryonic vascular formation and development, but also play an extremely important role in adult angiogenesis. With the concept of translational medicine presented, this biological characteristic of EPC is now being more and more introduced into the basic and clinical research in ischemic cerebrovascular disease. In this article, we try to summarize the current translational research progress of EPCs in ischemic cerebrovascular disease.
Keywords:Endothelial progenitor cells  Cerebrovascular disease, Ischemic  Translational medicine
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国卒中杂志》浏览原始摘要信息
点击此处可从《中国卒中杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号